End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.21 CNY | +0.65% | +1.27% | +2.17% |
Mar. 27 | Hengrui Pharma Gets Nod for Injectable Cancer Drug Trial | MT |
Mar. 19 | Hengrui Pharma Gets Green Light to Trial Four Cancer Drugs | MT |
Sales 2023 * | 23.47B 3.25B | Sales 2024 * | 27.11B 3.76B | Capitalization | 294B 40.69B |
---|---|---|---|---|---|
Net income 2023 * | 4.64B 643M | Net income 2024 * | 5.71B 791M | EV / Sales 2023 * | 11.7 x |
Net cash position 2023 * | 18.69B 2.59B | Net cash position 2024 * | 20.85B 2.89B | EV / Sales 2024 * | 10.1 x |
P/E ratio 2023 * |
63.5
x | P/E ratio 2024 * |
51.6
x | Employees | 20,636 |
Yield 2023 * |
0.35% | Yield 2024 * |
0.43% | Free-Float | 51.08% |
1 day | +0.65% | ||
1 week | +1.27% | ||
Current month | +8.37% | ||
1 month | +9.42% | ||
3 months | +3.26% | ||
6 months | +2.83% | ||
Current year | +2.17% |
Managers | Title | Age | Since |
---|---|---|---|
Hong Bin Dai
CEO | Chief Executive Officer | 48 | 00-06-30 |
Jian Jun Liu
DFI | Director of Finance/CFO | 47 | 21-11-18 |
Yu Xu
CMP | Compliance Officer | 32 | 21-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jie Ping Sun
BRD | Director/Board Member | 54 | 97-12-31 |
Hong Bin Dai
CEO | Chief Executive Officer | 48 | 00-06-30 |
Piao Yang Sun
CHM | Chairman | 66 | 03-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.18% | 2 M€ | -16.09% | - | |
3.73% | 2 M€ | -14.14% | ||
1.74% | 1 M€ | -9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 46.21 | +0.65% | 21,401,940 |
24-03-27 | 45.91 | -0.78% | 15,566,810 |
24-03-26 | 46.27 | +0.24% | 20,006,070 |
24-03-25 | 46.16 | +0.50% | 23,261,950 |
24-03-22 | 45.93 | +0.66% | 24,225,420 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.17% | 40.66B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |